ABSTRACT. This study measured Fc gamma receptor GPI, glycosyl-phosphatidylinositol (FcR) expression on polymorphonuclear leukocytes IVIG, i.v. administered IgG (PMN) and monocytes from extremely premature infants.
Premature infants' PMN expressed less FcR1ll, measured Bacterial infections, especially those caused by group B strepas mean log (MCF), than did term tococci, continue to be a major cause of neonatal morbidity and infants or adults (MCF = 4.7 f 1.4, 6.1 f 1-09 and 8.8
mortality, particularly among low-birth-weight infants (1-3). premature and term infants There are three major types of phagocytic cell-surface receptors had fewer FcR1l positive PMN than did (mean ' for IgG, but only two types are generally present on the surface SEM = 0.90 ' 0-09 and Oag9 ' Oao7 versus 0.99 ' O.OO, of PMN (17) . Most numerous is FcRIII, with about 100 000 p < 0.050). Premature infants' mon"cytes also receptors per adult PMN (17) . FcRIII binds dimeric IgG cornless FcR1ll (MCF = 2.4 ' versus 3. 4 ' plexes with a relatively low affinity but appears important in the 0.9, p = 0.047) and FcRII (2.1 2 0.5 versus 2-9 f 0.6, P = phagocytosis of opsonized bacteria and some unopsonized bac-0.01) compared with adults. We conclude that extremely teria and may be important in chernotaxis and adherence as well premature infants have decreased expression of FcRIII and (1 1, 17 The 12 term infants (gestational age 237 wk) were also admitted to the NICU during the study period and were sampled within 10 d of birth. They had a mean BW of 3483 k 5 19 g with a median of 3562 g (range, 2514 to 4330 g) and a mean gestational age of 38 f 1 wk with a median of 38 wk (range, 37 to 40 wk). They had the following diagnoses: congenital heart disease (n = 8), meconium aspiration (n = I), myelomeningocele (n = I), hydronephrosis (n = I), and pneumothorax (n = 1). Expression of one or more PMN receptors was also examined in 37 healthy adult volunteers. Eleven premature infants had followup evaluations (sample volume, 100 to 500 pL) at least 10 d after their initial sampling (median, 29 d; range 1 1 to 73 d). Informed consent was obtained from all participants in this study, their parents, or guardians except in the case of waste blood remaining after routine hematologic testing; waste blood was used anonymously. This project was approved by the Minneapolis Children's Medical Center Institutional Review Board for the Protection of Human Subjects.
Specimen and clinical data collection. Specimens were obtained through indwelling vascular catheters or by heelstick and were anticoagulated with EDTA. BW, estimated gestational age (based on physical exam), gender, chronologic age, 5-min Apgar scores, eosinophil count, immature PMN count, route of delivery (vaginal or cesarean), presence of maternal chorioamnionitis (based on maternal findings or placental histology), WBC, and absolute neutrophil count on the day of specimen collection, ventilator settings, arterial blood pressure at the time of specimen collection, and the results of initial blood cultures were recorded for each infant.
Isolation ofPMN and monocytes from whole blood. PMN and monocytes were usually stained in whole blood. In selected experiments, PMN were isolated by layering up to 1 mL of whole blood over 1 mL of cold Isolymph (Gallard-Schlesinger, Carle Place, NY) and centrifuging at 400 x g for 30 min at 4°C. The red blood cell/PMN pellet was washed and resuspended in PBS to the original volume. White blood cells remaining after these procedures were 95 f 3% PMN as determined by light micros-COPY.
Monocytes were partially purified using the same procedure, except that the mononuclear cell layer was retained, washed, and stained with MAb. Mononuclear cell preparations contained 4 k 4% PMN by examination of slides prepared by cytocentrifuging samples onto glass slides. Ninety-two f 11% of the mononuclear cells identified as monocytes by small-and right-angle light scatter were confirmed to be monocytes by MY9 staining and flow cytometry analysis.
MAb and cell staining. FITC-conjugated MAb 3G8 (IgGl subtype, anti-FcRIII), IV.3 (IgG2b, anti-FcRII), and 32.2 (IgGl, anti-FcRI) were obtained from Medarex (West Lebanon, NH); 80H 1 3 (IgG 1, anti-CD67), from AMAC (Westbrook, ME); and 322A-1 (IgG2b, anti-CD 14) and phycoerythrin-conjugated MY9 (IgG2b, anti-monocyte), from Coulter Laboratories (Hialeah, FL). FITC-conjugated or phycoerythrin-conjugated control MAb directed against irrelevant antigens but with matching isotypes were purchased from Coulter (IgG1, IgG2b). FcR MAb (20 pg/ mL), anti-CD67 (20 pg/mL), anti-MY9 (1 pg/mL), or anti-CD14 (1 pg/mL) was added to 50 to 100 pL of blood according to the manufacturers' directions. The same concentrations were used to stain with the irrelevant control MAb. After a 30-min incubation at 4"C, the red blood cells were lysed and the PMN fixed using Immuno-Prep (Coulter) according to the manufacturer's directions.
Flow cytometric evaluation. All specimens were examined on an EPICS PROFILE I1 flow cytofluorometer (Coulter). PMN and monocyte data were selected, and 5000 cells were analyzed by flow cytometry. Other cells were excluded from subsequent analysis based on small-and right-angle light scatter. Standardization of fluorescence was performed daily using fluorescent microbeads (Standard-Brite beads, Coulter). Control samples included neonates' and adults' PMN stained with the isotypematched, control MAb. Results from samples stained with control MAb were used to exclude from analysis 298% of nonspecifically stained cells. The resulting receptor expression was measured as cell-surface fluorescence intensity and is reported as MCF on a four-decade log scale. The proportion of fluorescencepositive cells and examination of the actual fluorescence histograms were used to evaluate cell-surface antigen expression.
To evaluate release of FcRIII antigen, some specimens were examined immediately, stored at 4°C for over 3 h, and reexamined. These samples had very similar FcRIII expression before and after storage (MCF = 8.8 f 1 .O versus 8.7 f 1.0, n = 2 adults and MCR = 4.0 f 0.5 versus 4.0 f 0.9, n = 4 premature infants).
Statistical analysis. Results from multiple specimens obtained from the same adult and stained with the same MAb on different days were averaged. Differences in MCF and the proportion of FcRIII-or FcRII-positive cells among specimens from adults and premature and term infants were evaluated using a one-way analysis of variance with Scheffe's test for multiple comparisons. Examination of differences between samples prepared with and without PMN isolation procedures was performed with paired t test. Other comparisons between two sample groups were performed using independent, two-tailed t tests. Multivariate analysis was performed with multiple linear regression to examine the association of clinical features with FcRIII and FcRII expression. Measures of dispersion about the mean are presented as mean f SD unless otherwise noted. A p value <0.050 was considered significant. Commercial software (SPSS, Inc, Chicago, IL or MacSS, Statsoft, Tulsa, OK) was used for all calculations.
RESULTS
FcRIII expression on PMN. Premature infants expressed significantly less FcRIII on their PMN than did adults (Table 1) . FcRIII expression per PMN of term infants was intermediate between that of premature infants and adults (Table 1 ). Figure 1 shows representative histograms from anti-FcRIII staining of a premature neonate's and an adult's PMN. Premature infants' cell fluorescence histograms were wider than those obtained from adults' PMN and suggested that FcRIII antigen expression on premature infants' PMN was not only decreased but also more variable from cell to cell than that on adults' PMN.
The proportion of PMN that stained positively for FcRIII was also lower in premature infants than in term infants or adults (Table I ). The 95% confidence intervals for the proportion of FcRIII-positive PMN from premature infants did not overlap those from adults (Table I ). These results indicated that premature infants had fewer PMN expressing detectable FcRIII antigen and less FcRIII antigen per PMN when compared with either adults or term infants.
FcRIII expression on partially puriJied PMN. To validate the whole-blood staining technique, we compared FcRIII expression in premature infants and adults after PMN staining in partially purified cell suspensions or in whole blood. PMN purification procedures significantly increased FcRIII expression on the PMN of both premature infants and adults (Table 2) . However, as in whole-blood samples, FcRIII expression on isolated PMN remained significantly lower in premature infants than adults, and the proportion of FcRIII-positive cells among isolated PMN also (-) and the fluorescence of the adult's PMN after staining with an isotypic control, murine MAb, directed against an irrelevant antigen (---). The abscissa indicates MCF and the ordinate shows the relative cell number. Expression of FcRI on PMN. FcRI is usually found on monocytes and macrophages rather than PMN (17) . However, FcRI has been reported to be increased on PMN from patients with leukocyte adhesion deficiency (19) and after culture of PMN with interferon-? (1 7). We reasoned that FcRI might be increased on premature infants' PMN to compensate for decreased FcRIII expression. FcRI expression varied little between the PMN of adults and premature infants, except that premature infants had a greater proportion of FcRI-positive cells than did adults (Table  3) .
Expression of other GPI-anchored proteins (CD14, CD67). FcRIII, CD14, and CD67 are anchored to the cell membrane by a GPI linkage rather than by a transmembrane attachment (20, 2 1). The expression of GPI-anchored proteins, CD14 (22) and CD67 (23), were not significantly different between premature infants and adults (Table 3 ). CD67 expression was greater (Table   3 ) on the PMN of premature infants than on those of adults; however, these changes did not reach statistical significance ( p = 0.065).
Expression of FcR, CD14, and CD67 proteins on monocytes. To investigate whether decreased FcRIII and FcRII expression on PMN was an isolated finding or also present on other myeloid cells, we examined FcR expression on monocytes. Premature infants expressed less FcRIII and less FcRII per monocyte than did adults using whole-blood staining (Table 4) . To confirm the decreased FcRIII expression on monocytes, we prepared partially purified monocyte suspensions and compared FcRIII expression with that of MY9, an antigen not expressed on mature blood cells other than monocytes. Premature infants (n = 7) and adults (n = 6) did not differ in MY9 expression (MCF = 3.3 k 0.9 versus 3.2 f 1. l), although FcRIII expression was again shown to be reduced on the monocytes of premature infants (MCF = 3.8 + 0.6 versus 2.0 f 0.9, p = 0.001).
The monocyte expression of FcRI, CD14, or CD67, as expressed by MCF, did not differ between adults and premature infants (Table 4 ). There were significant differences between adults and infants in the proportions of monocytes staining positive for the various antigens. Premature infants had a significantly larger proportion of FcRIII-and CD67-positive monocytes than did adults but a lower proportion of FcRII-, FcRI-, and CD 14-positive monocytes than adults (Table 4 ).
DISCUSSION
Premature infants had not only decreased FcRIII expression per PMN but also fewer PMN expressing any detectable FcRIII antigen compared with adults ( Table 1 ). The premature infants had MCF values for FcRIII expression on PMN that were 53% of adult controls in this study compared with 63% in the study of Smith et al. (9) and 7 1 % in the study of Carr and Davies (10).
Our data also suggested that premature infants' PMN express less FcRII ( p = 0.004) on their PMN than adults. C a n and Davies (10) reported that FcRII expression on the PMN from premature infants was about 88% of that on adults' PMN compared with 80% of adult controls reported here.
We did not confirm Carr and Davies' (10) association between FcRIII expression and clinical variables such as sepsis and respiratory distress syndrome. Our study differed from theirs in several ways: our patient sample was larger (n = 64 versus 27), had a lower BW (median = 845 versus 962 g), was more homogenously immature (BW range = 480 to 1234 versus 693 to 1800 g), was less likely to have early-onset bacteremia (two of 64, 3% versus five of 27, 19%), and was more likely to receive pulmonary surfactant treatment. Our surfactant-treated patients rarely required high levels of ventilator support and may have been less "stressed" than those in other studies.
There are two possible explanations for decreased FcRIII expression on the PMN of premature infants. Either FcRIII production and/or transport to the cell surface is decreased or FcRIII release from the cell membrane is increased. This study found evidence to support both potential mechanisms.
In this study, FcRIII expression on the PMN of extremely premature neonates was significantly increased by PMN isolation procedures (Table 2) . Cytokines also modulate FcRIII expression on the surface of PMN (24, 25) . Because neonatal cells produce less interferon-7 (26), granulocyte-colony-stimulating factor (27) , and tumor necrosis factor (28) than adult cells, one might expect decreased FcRIII expression to be due to decreased circulating levels of cytokines. The fact that FcRII expression on PMN and FcRIII expression on monocytes are both decreased indicates that several different receptors are down-regulated and is consistent with decreased receptor production and/or transport to the cell surface.
An alternative explanation for the decreased FcRIII expression on premature infants' PMN relates to the GPI linkage attaching
FcRIII to the cell membrane. This linkage permits release of 
* Expression of these cell surface antigens differed significantly in the case of FcRIII ( p = 0.047, two-tailed, independent t test) and FcRII ( p = 0.010). FcRIII protein in response to stimulation of PMN with N-formylmethionyl-leucyl-phenylalanine (29, 30) , phorbol myristate acetate (29, 30) , and other stimuli (30) . Premature infants' PMN may produce normal amounts of FcRIII but release it more readily, resulting in lowered surface expression. A generalized defect in the formation of GPI anchors seems unlikely, inasmuch as adults and premature infants did not differ in the expression of two other GPI-anchored proteins, CD14 and CD67, on either PMN or monocytes. We also considered the possibility of FcRIII release during specimen processing. However, specimens were collected in EDTA, which effectively inhibits the release of FcRIII (30), and we saw little change in FcRIII expression by PMN after storing specimens for 3 h (see Materials and Methods). The possibility of in vivo release of FcRIII is still quite possible, and both decreased production/transport and increased release may combine to reduce FcRIII expression on the PMN of premature neonates.
The consequences of decreased FcRIII and FcRII expression for premature infants are not known. However, we suspect that FcRIII and FcRII are important to the phagocytosis of bacterial pathogens for several reasons. Destruction of IgG-coated platelets is reduced after administration of anti-FcRIII in patients with idiopathic thrombocytopenia (3 l), indicating that FcRIII is important to the in vivo phagocytosis of IgG-coated particles. Furthermore, FcRIII appears to be important to the in vitro phagocytosis of neonatal pathogens, coagulase-negative staphylococci (12) , and group B streptococci (16) . Therefore, reduced FcRIII expression on PMN of extremely premature infants may significantly weaken host defenses against bacterial infection and predispose infants to infection.
Reduced expression of FcRIII and FcRII may affect PMN function and the efficiency of IVIG infusion in the prevention (32, 33) or treatment of bacterial infections in prematurely born neonates (34) . At least part of the potential effectiveness of IVIG resides in its ability to opsonize bacteria and then serve as a ligand binding the bacteria to the PMN via FcR. Deficiencies in neonates' expression of FcR may render IVIG ineffective in premature infants with low levels of FcRIII expression or, conversely, may optimize the function of the lower number of FcRIII receptors that are present on these infants' PMN.
The identification of specific defects in the host defenses of premature infants, such as reduced FcRIII and FcRII expression, should lead to a better understanding of the causes of neonates' susceptibility to bacterial infections. Elucidation of these defects may also lead to more specific and effective therapeutic innovations.
